1. Home
  2. CMCO vs CGEM Comparison

CMCO vs CGEM Comparison

Compare CMCO & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Columbus McKinnon Corporation

CMCO

Columbus McKinnon Corporation

HOLD

Current Price

$17.62

Market Cap

492.7M

Sector

Industrials

ML Signal

HOLD

Logo Cullinan Oncology Inc.

CGEM

Cullinan Oncology Inc.

HOLD

Current Price

$10.10

Market Cap

671.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMCO
CGEM
Founded
1875
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
492.7M
671.7M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
CMCO
CGEM
Price
$17.62
$10.10
Analyst Decision
Hold
Strong Buy
Analyst Count
1
8
Target Price
$35.00
$28.00
AVG Volume (30 Days)
218.2K
1.6M
Earning Date
02-09-2026
11-06-2025
Dividend Yield
1.59%
N/A
EPS Growth
N/A
N/A
EPS
0.13
N/A
Revenue
$977,994,000.00
N/A
Revenue This Year
$5.60
N/A
Revenue Next Year
$4.23
N/A
P/E Ratio
$133.97
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.78
$5.68
52 Week High
$38.31
$13.33

Technical Indicators

Market Signals
Indicator
CMCO
CGEM
Relative Strength Index (RSI) 61.90 48.62
Support Level $17.00 $9.48
Resistance Level $17.67 $10.38
Average True Range (ATR) 0.53 0.92
MACD -0.03 -0.30
Stochastic Oscillator 64.71 16.44

Price Performance

Historical Comparison
CMCO
CGEM

About CMCO Columbus McKinnon Corporation

Columbus McKinnon Corp is a designer, manufacturer, and marketer of intelligent motion solutions, including motion control products, technologies, automated systems, and services that efficiently and ergonomically move, lift, position, and secure materials. Its key products include hoists, crane components, precision conveyors, actuators, rigging tools, light rail workstations, and digital power and motion control systems. The company's targeted market verticals include general industries, process industries, industrial automation, and e-commerce/supply chain/warehousing among others. Geographically, the company generates a majority of its revenue from the United States and the rest from Germany, Canada, Asia Pacific, Latin America, Europe, the Middle East, and Africa.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: